Boston Scientific (BSX) Invested Capital (2009 - 2026)

Boston Scientific has disclosed Invested Capital across 18 years of filings, most recently posting $26.5 billion for Q1 2026.

• Invested Capital for Q1 2026 came in at $26.5 billion, down 21.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.5 billion (down 21.63% YoY), and the FY2025 annual result was $24.7 billion, up 13.38% from the prior year.
• Invested Capital came in at $26.5 billion for Q1 2026 at Boston Scientific, up from $24.7 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $35.2 billion in Q3 2025 to a low of -$60.0 million in Q2 2025.
• The 5-year median for Invested Capital is $23.3 billion (2022), against an average of $19.3 billion.
• Across the five-year window, Invested Capital surged 1033.94% in 2023 and plunged 100.56% in 2025, its largest moves.
• Boston Scientific's Invested Capital stood at $2.5 billion in 2022, then soared by 1033.94% to $28.6 billion in 2023, then declined by 23.97% to $21.8 billion in 2024, then climbed by 13.38% to $24.7 billion in 2025, then climbed by 7.17% to $26.5 billion in 2026.
• The last three Invested Capital figures came in at $26.5 billion (Q1 2026), $24.7 billion (Q4 2025), and $35.2 billion (Q3 2025), per Business Quant data.